Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Phytosol India Private Limited currently faces 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution activity is concentrated under 1 distinct examiner and 1 distinct art unit, suggesting a narrow scope of current patent office engagement. With this pending action count, the company's immediate prosecution profile is highly sensitive to the decisions of this examiner. This concentration provides a clear focus for the company's legal strategy.
WISTNER, SARAH CLINKSCALES is the busiest examiner for the portfolio. This examiner is managing 1 pending office action, which represents the total pending workload for the company at this time. Because the entire pending portfolio is under the review of this examiner and 1 distinct art unit, the company must align its arguments with the specific technical standards of that unit. The assigned art unit serves as the primary focal point for the company's current intellectual property efforts, requiring a dedicated approach to the 1 pending action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WISTNER, SARAH CLINKSCALES | 1 | 25.8% | +73.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918912 | A SAPOGENIN POLYETHYLENE GLYCOL ESTER COMPLEX OF FORMULA-I, A COMPOSITION, PROCESS OF PREPARATION, AND APPLICATIONS THEREOF | WISTNER, SARAH CLINKSCALES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918912 | A SAPOGENIN POLYETHYLENE GLYCOL ESTER COMPLEX OF FORMULA-I, A COMPOSITION, PROCESS OF PREPARATION, AND APPLICATIONS THEREOF | WISTNER, SARAH CLINKSCALES | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17918912 | A SAPOGENIN POLYETHYLENE GLYCOL ESTER COMPLEX OF FORMULA-I, A COMPOSITION, PROCESS OF PREPARATION, AND APPLICATIONS THEREOF | WISTNER, SARAH CLINKSCALES | 1616 | §103 | Final Rejection | — | Pending | Oct 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPhytosol India Private Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Sarah Clinkscales Wistner has the most, with 1 of Phytosol India Private Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.